Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced…
Category: Health
[featured-content cat_id=”36″]
[featured-content-slider cat_id=”36″]
UM SCHOOL OF MEDICINE RESEARCHERS CHART PATH FORWARD ON DEVELOPING MRNA VACCINES FOR INFECTIONS BEYOND COVID-19
After helping to develop and test new mRNA technologies for COVID-19 vaccines, University of Maryland School of…
Massage Heights Announces Launch of New Facial Service, Strengthens Position as Skincare Experts
As the wants and needs of consumers change over time, Massage Heightsresponds with service innovation and evolution.…
National Kidney Foundation Appoints Vizient, Inc. Executive to National Board of Directors
The National Kidney Foundation (NKF) is thrilled to announce the appointment of Monica Davy, Senior Vice President and Chief…
Marine pharmaceuticals market size to grow at a CAGR of 7.73%, from 2021 to 2026: Licensing agreements to drive growth – Technavio
The marine pharmaceuticals market size is estimated to increase by USD 1.56 billion from 2021 to 2026, with a CAGR…
Global Mouth Ulcer Treatment Market to 2027: Increasing Oral Problems Worldwide Bolsters Growth
The “Mouth Ulcer Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by…
Choose Health Expands Testing Platform with Private Label At-Home Blood Tests
Choose Health has announced it is expanding its product line to offer private label at-home blood tests…
U-Earth Launches the Next Generation supplement: Hyper-U
European biotech company U-Earth Store has launched a revolutionary natural supplement called Hyper-U that aims to promote optimal physical and mental well-being. The holistic solution is…
Hereford Proteins Hosts Year of Hereford® Corned Beef Sweepstakes
Calling all home chefs and corned beef lovers! Hereford Proteins—a provider of high-quality, non-perishable protein products since…
FDA accepts sBLA for traditional approval of LEQEMBI™ (lecanemab-irmb) for the treatment of Alzheimer’s disease and grants Priority Review: BioArctic
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the U.S. Food and…